Update comment: 16th Mar. I've been wondering if this might in fact be a limited hangout op, in that though blood clot risk might well be heightened to a certain extent, in fact it could be one of the lesser [sic] safety concerns of 'the jab'. I mean that it might be a limited hangout to deal with the ever increasing public push back and so-called 'vaccine hesitancy' (wow what a loaded/biased new linguistic term!). Like, several countries' authorities are taking the blood clot risk seriously and looking into it - but if/when they come back and give the 'all clear' again then essentially it will give the impression that all the far more serious concerns about 'the jab' have also been dealt with (or even that there are no greater safety concerns anyway). Also, it might make it easier for the authorities to deal with future concerns, with them able to suggest it's just another 'crying wolf' thing like the last set of concerns. But the real question and concern is, what is 'the jab' really for (and the dangers and genetic corruption surrounding such a purpose).

On the other hand, any interruption could be viewed as beneficial - as in, 'getting a foot in the door' is a first step in terms of bringing a halt to the ongoing madness, even if at this time it comes to very little.

Note, as well as the proxy links below, both the letter to the EMA (European Medicines Agency) and the associated press release are embedded as PDFs below - plus in addition, the letter, press release as well as the accompanying video, can all be found in this server folder here.

Given the signatories to the letter, and their individual and combined knowledge and experience, this letter is an extremely important (legal) submission to the EMA (European Medicines Agency) - and would appear to be why so many countries over the last 24 hours have suspended use of mRNA based COVID-19 vaccinations.

• The press release about the letter (and which provides a useful overview) can be read in Google PDF reader here and/or be found in this folder.
• The submitted letter itself is embedded below and/or can also be read in Google PDF reader here and/or be found in this folder.
• A 7 min video statement supporting the letter, by Professor Sucharit Bhakdi (Professor Emeritus of Medical Microbiology and Immunology and Former Chair, Institute of Medical Microbiology and Hygiene) can be viewed on lbry.tv here. This statement also details the main concern expressed in the letter. It is well worth hearing imo.

The signatories to the letter are:

• Professsor Sucharit Bhakdi MD, Professor Emeritus of Medical Microbiology and Immunology, Former Chair, Institute of Medical Microbiology and Hygiene, Johannes Gutenberg University of Mainz (Medical Doctor and Scientist) (Germany and Thailand)
• Dr Marco Chiesa MD FRCPsych, Consultant Psychiatrist and Visiting Professor, University College London (Medical Doctor) (United Kingdom and Italy)
• Dr C Stephen Frost BSc MBChB Specialist in Diagnostic Radiology, Stockholm, Sweden (Medical Doctor) (United Kingdom and Sweden)
• Dr Margareta Griesz-Brisson MD PhD, Consultant Neurologist and Neurophysiologist (studied Medicine in Freiburg, Germany, speciality training for Neurology at New York University, Fellowship in Neurophysiology at Mount Sinai Medical Centre, New York City; PhD in Pharmacology with special interest in chronic low level neurotoxicology and effects of environmental factors on brain health), Medical Director, The London Neurology and Pain Clinic (Medical Doctor and Scientist) (Germany and United Kingdom)
• Professor Martin Haditsch MD PhD, Specialist (Austria) in Hygiene and Microbiology, Specialist (Germany) in Microbiology, Virology, Epidemiology/Infectious Diseases, Specialist (Austria) in Infectious Diseases and Tropical Medicine, Medical Director, TravelMedCenter, Leonding, Austria, Medical Director, Labor Hannover MVZ GmbH (Medical Doctor and Scientist) (Austria and Germany)
• Professor Stefan Hockertz, Professor of Toxicology and Pharmacologym, European registered Toxicologist, Specialist in Immunology and Immunotoxicology, CEO tpi consult GmbH. (Scientist) (Germany)
• Dr Lissa Johnson, BSc BA(Media) MPsych(Clin) PhD, Clinical Psychologist and Behavioural Psychologist, Expertise in the social psychology of torture, atrocity, collective violence and fear propaganda, Former member Australian Psychological Society Public Interest Advisory Group (Clinical Psychologist and Behavioural Scientist) (Australia)
• Professor Ulrike Kämmerer PhD, Associate Professor of Experimental Reproductive Immunology and Tumor Biology at the Department of Obstetrics and Gynaecology, University Hospital of Würzburg, Germany, Trained molecular virologist (Diploma, PhD-Thesis) and Immunologist (Habilitation), Remains engaged in active laboratory research (Molecular Biology, Cell Biology (Scientist) (Germany)
• Associate Professor Michael Palmer MD, Department of Chemistry (studied Medicine and Medical Microbiology in Germany, has taught Biochemistry since 2001 in present university in Canada; focus on Pharmacology, metabolism, biological membranes, computer programming; experimental research focus on bacterial toxins and antibiotics (Daptomycin); has written a textbook on Biochemical Pharmacology, University of Waterloo, Ontario, Canada (Medical Doctor and Scientist) (Canada and Germany)
• Professor Karina Reiss PhD, Professor of Biochemistry, Christian Albrecht University of Kiel, Expertise in Cell Biology, Biochemistry (Scientist) (Germany)
• Professor Andreas Sönnichsen MD, Professor of General Practice and Family Medicine, Department of General Practice and Family Medicine, Center of Public Health, Medical University of Vienna, Vienna (Medical Doctor) (Austria)
• Dr Michael Yeadon BSc (Joint Honours in Biochemistry and Toxicology) PhD (Pharmacology), Formerly Vice President & Chief Scientific Officer Allergy & Respiratory, Pfizer Global R&D; Co-founder & CEO, Ziarco Pharma Ltd.; Independent Consultant (Scientist) (United Kingdom)